- Jarden downgraded Integral Diagnostics to Neutral from Buy.
- No price target or reasoning was disclosed.
Jarden lowered its rating on Integral Diagnostics to Neutral from Buy. The note did not include a price target or stated rationale.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.